CCR7 and neoplasm: The authors concluded that, although the study did not find evidence that the CCR7 protein is a useful predictor of lymph node metastasis, disease-free recurrence, or breast cancer-specific survival, its expression was associated with an altered tumor microenvironment, which might affect the capability of tumors to spread through lymphatic vessels.